PC-3M-luc cells and DU145 cells were cultured in EMEM (Lonza, Basel, Switzerland, 12–125) supplemented with 10% FCS, 1% L-glutamine (Lonza,
BE17-605E) and 1% penicillin-streptomycin (Lonza,
DE17-602E). RNAi knockdown was performed using
Dharmafect 2 (Thermo Scientific, Waltham, MA, USA, T-2002-01) in PC-3M cells and
Dharmafect 4 (Thermo Scientific, T-2004-01) in DU145 cells using 25 n
M siRNA according to the manufacturer's instruction. For knockdown of LSD1 the following siRNAs were used: siCtrl: 5′-AACGTACGCGGAATACTTCGA-3′ and siLSD1 5′-acacaaggaaag cuagaagaa-3′. For others siCtrl 5′-GAAAGTCCTAGATCCACACGCAAAT-3′, siLPAR6 5′-UCAGCAUGGUGUUUGUGCUUGGGUU-3′, siPXN 5′-CATACCCAACTGGAAACCACACATA-3′, siTLN1 5′-CATTGTACTTGATACGGCCAGTGAT-3′, siZYX 5′-CAGGGAGAAGGTGAGCAGTATTGAT-3′ and siPIK3R2 5′-CCCTCAGGAAAGGCGGGAACAATA-3′.
Dharmafect Duo (Thermo Scientific, T-2010-01) was used for plasmid transfection as described in the manual.
Puromycin (Sigma, St Louis, MO, USA, P8733, 5 μg/ml) was administered to cells 24 h post transfection. 293T cells were cultured in DMEM supplemented with 10% FCS, 1% L-glutamine and 1% penicillin-streptomycin. Viral production was performed as described.
12 (link) PC-3M cells were infected with FU-GFP or FU-GFP-LSD1 and subjected to migration assay 24 h post transduction.
Ketscher A., Jilg C.A., Willmann D., Hummel B., Imhof A., Rüsseler V., Hölz S., Metzger E., Müller J.M, & Schüle R. (2014). LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6. Oncogenesis, 3(10), e120.